Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Bupivacaine in open gynecologic surgery
NCT02740114Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Aug 2016
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of liposomal bupivacaine in malignant neoplasm of female genital organs, sponsored by University of Texas MD Anderson Cancer Center. Started Aug 2016; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
malignant neoplasm of female genital organs
Beyond the preview
Go deeper on NCT02740114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02740114.